Company
Headquarters: Beijing, China
Employees: 9,209
CN¥15.29 Billion
CNY as of July 1, 2024
US$2.10 Billion
Company | Market Cap (USD) |
---|---|
McKesson Corporation | $75.67 B |
Cencora, Inc. | $43.82 B |
Cardinal Health, Inc. | $23.31 B |
Shanghai Pharmaceuticals Holding Co. Ltd | $8.79 B |
Sinopharm Group Co. Ltd | $8.37 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company imports and exports China national medicines and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral drugs; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products and raw materials; chemical raw materials; and nutritional and other healthcare products. The company also plants, processes, warehouses, and transports ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and other herbs. China Meheco Group Co., Ltd. was founded in 1984 and is based in Beijing, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
China Meheco Group Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600056 wb_incandescent